| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 02/20/2003 | WO2003014366A2 Rna amplification system using plant components in animal cells |
| 02/20/2003 | WO2003014360A1 SURFACE EXPRESSION VECTORS HAVING pgsBCA, THE GENE CODING POLY-GAMMA-GLUTAMATE SYNTHETASE, AND A METHOD FOR EXPRESSION OF TARGET PROTEIN AT THE SURFACE OF MICROORGANISM USING THE VECTOR |
| 02/20/2003 | WO2003014358A2 Detergent and cleaning agent with hybrid alpha amylases |
| 02/20/2003 | WO2003014357A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | WO2003014356A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | WO2003014355A1 Nitrilase gene |
| 02/20/2003 | WO2003014354A1 Tyrosyl-trna synthase variants |
| 02/20/2003 | WO2003014342A2 Identification of a dna variant associated with adult type hypolactasia |
| 02/20/2003 | WO2003014341A2 Chimeric proteins comprising a haem domain of a mammalian or plant cytochrome p450 and a scaffold-reductase domain from p450 bm3 of bacillus megaterium and uses thereof |
| 02/20/2003 | WO2003014340A2 Human histone deacetylase-related gene and protein hdac10 |
| 02/20/2003 | WO2003014339A2 Carbohydrates and polyols for dissolving protein crystals |
| 02/20/2003 | WO2003014324A2 Thermostable uvra and uvrb polipeptides and methods of use |
| 02/20/2003 | WO2003014321A2 Compositions and methods for modulation of darpp-32 phosphorylation |
| 02/20/2003 | WO2003014308A2 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 02/20/2003 | WO2003014148A2 Human fatty acid-coa ligase |
| 02/20/2003 | WO2003013234A2 Method for the in vivo screening of the biological activity of an acetylcholinesterase inhibitor compound on one or more cellular targets other than acetylcholinesterase |
| 02/20/2003 | WO2003013226A2 Non-transgenic herbicide resistant plants |
| 02/20/2003 | WO2003013225A2 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | WO2003002733A3 Compositions for enhanced catalyzed reporter deposition |
| 02/20/2003 | WO2003002063A3 Structure-based drug design methods for identifying d-ala-d-ala ligase inhibitors as antibacterial drugs |
| 02/20/2003 | WO2002092769A3 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication |
| 02/20/2003 | WO2002086085A3 Human timp-1 antibodies |
| 02/20/2003 | WO2002077242A3 Family 74 xyloglucanases |
| 02/20/2003 | WO2002068607A3 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 02/20/2003 | WO2002064738A3 Modified target enzymes having catalytic triads and uses thereof |
| 02/20/2003 | WO2002062976A3 Serine proteases |
| 02/20/2003 | WO2002062974A3 Regulation of human elongase hselo1-like protein |
| 02/20/2003 | WO2002061065A3 Phosphorylated glyoxalase i and its use |
| 02/20/2003 | WO2002061057A3 Regulation of human wee1-like serine/threonine protein kinase |
| 02/20/2003 | WO2002053170A3 Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with fo |
| 02/20/2003 | WO2002052012A8 Sugar beet genes involved in stress tolerance |
| 02/20/2003 | WO2002046441A3 Targets for herbicides and transgenic plants resistant to said herbicides |
| 02/20/2003 | WO2002044335A3 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions |
| 02/20/2003 | WO2002027322A9 Reagents, method and kit for detecting phosphinothricin-n-acetyltransferase protein |
| 02/20/2003 | WO2002026950A3 Transferases |
| 02/20/2003 | WO2002022783A8 Liver gene expression associated with the inhibition of hbv replication or transcription |
| 02/20/2003 | WO2002009646B1 Plant derived antioxidants |
| 02/20/2003 | WO2002003791A8 Transgenic mice containing targeted gene disruptions |
| 02/20/2003 | WO2001066766A3 A matrix metalloproteinase (mmp-25) expressed in skin cell |
| 02/20/2003 | WO2001064949A9 Diagnostics and therapeutics for glaucoma |
| 02/20/2003 | US20030037357 Plant acyl-CoA synthetases |
| 02/20/2003 | US20030037350 Nucleotide sequences coding polypeptides for use in the treatment and diagnosis of cancer and nervous system disorders |
| 02/20/2003 | US20030037347 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 02/20/2003 | US20030037346 Protein production system |
| 02/20/2003 | US20030036647 Nucleotide sequences coding polypeptide for use in pharmocology and drug screening |
| 02/20/2003 | US20030036635 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036634 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036632 Protein for use in the treatment of alzheimer's, muscle, nervous system and thrombocytopenia |
| 02/20/2003 | US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease. |
| 02/20/2003 | US20030036517 Identifying accessible regions in a target RNA molecule using trans-splicing nucleic acid molecules |
| 02/20/2003 | US20030036501 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 02/20/2003 | US20030036184 Polypeptides exhibiting PDE7 activity and their use for selecting compounds which inhibit PDE 7 enzyme activity |
| 02/20/2003 | US20030036183 Serine threonine kinase member, h2520-40 |
| 02/20/2003 | US20030036180 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders |
| 02/20/2003 | US20030036179 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036178 Long wavelength engineered fluorescent proteins |
| 02/20/2003 | US20030036172 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases |
| 02/20/2003 | US20030036171 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 02/20/2003 | US20030036170 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 02/20/2003 | US20030036167 Protease proteins that are related to the choriolytic hatching protease subfamily, recombinant DNA molecules, and protein production. |
| 02/20/2003 | US20030036165 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders |
| 02/20/2003 | US20030036162 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036161 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036146 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders |
| 02/20/2003 | US20030036140 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036137 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders |
| 02/20/2003 | US20030036121 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036119 Nucleotide sequences coding polypeptides for use in the treatment, diagnosis and prevention of cell proliferative disorders |
| 02/20/2003 | US20030036118 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036116 Can be used in combination with other mutagenesis methods |
| 02/20/2003 | US20030036112 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders |
| 02/20/2003 | US20030036102 Cathepsin differentially expressed in lung cancer |
| 02/20/2003 | US20030036094 Nucleotide sequences coding polypeptide for use in the treatment of kidney, skin and cancer disorders |
| 02/20/2003 | US20030036092 Directed evolution of enzymes and antibodies |
| 02/20/2003 | US20030036075 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders |
| 02/20/2003 | US20030036074 Novel nucleic acid sequences encoding human transporters, a human atpase molecule, a human ubiquitin hydrolase-like molecule, a human ubiquitin conjugating enzyme-like molecule, and uses therefor |
| 02/20/2003 | US20030036061 Nucloetide sequences coding polypeptide for use in the treatment and diagnosis of infections,cancer, skin, cardiovascular and gastrointestinal disorders |
| 02/20/2003 | US20030036060 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036056 Inhibitors and target molecule co-localization |
| 02/20/2003 | US20030036051 Methods of screening for antagonists and agonists of polypeptides having kinase functions |
| 02/20/2003 | US20030036050 Recovering enzyme mutant of preferential activity; obtain mutants, display mutants on solid support, monitor structure and activity of mutant |
| 02/20/2003 | US20030035794 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders |
| 02/20/2003 | US20030035792 Recombinant MVA virus, and the use thereof |
| 02/20/2003 | US20030035789 Purging lymphocytes |
| 02/20/2003 | US20030034993 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | CA2808328A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | CA2790951A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | CA2759765A1 Control of development of biofilms in industrial process water |
| 02/20/2003 | CA2456942A1 Compositions and methods for modulation of darpp-32 phosphorylation |
| 02/20/2003 | CA2456719A1 Chimeric proteins comprising a haem domain of a mammalian or plant cytochrome p450 and a scaffold-reductase domain from p450 bm3 of bacillus megaterium and uses thereof |
| 02/20/2003 | CA2456565A1 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 02/20/2003 | CA2456311A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | CA2456117A1 Chimeric protein and its use in electron transfer methods |
| 02/20/2003 | CA2455512A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | CA2454686A1 Use of xylene monooxygenase for the oxidation of substituted monocyclic aromatic compounds |
| 02/20/2003 | CA2454246A1 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 02/19/2003 | EP1284298A2 Identification and use of molecules implicated in pain |
| 02/19/2003 | EP1284297A2 Identification and use of molecules implicated in pain |
| 02/19/2003 | EP1284293A2 Gene coding for cyclodextrin glucanotransferase chiefly producing gamma-cyclodextrin and use thereof |
| 02/19/2003 | EP1284286A1 Alpha-isomaltosyltransferase, process for producing the same and use thereof |